The immunopathogenesis of equine infectious anemia virus.
about
Structural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen AllelesEIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophagesEquine infectious anemia virus is found in tissue macrophages during subclinical infectionTissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equidsDevelopment and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domainCTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteinsEarly detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horsesAlthough macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccineDevelopment and characterization of an equine infectious anemia virus Env-pseudotyped reporter virusInfluence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.Nonregenerative anemia: mechanisms of decreased or ineffective erythropoiesis.Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus.Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.Leukoencephalitis associated with selective viral replication in the brain of a pony with experimental chronic equine infectious anemia virus infection.Development of antigen capture ELISA for the quantification of EIAV p26 protein.Epidemiology and genetic characterization of equine infectious anaemia virus strains isolated in Belgium in 2010.Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.The comparison of genetic variation in the envelope protein between various immunodeficiency viruses and equine infectious anemia virus.Development of a nested PCR assay to detect equine infectious anemia proviral DNA from peripheral blood of naturally infected horses.
P2860
Q27703610-51631059-6DD7-4047-B2AC-16A0CB7B4526Q33237979-AC5300CC-D1DB-4E85-812F-F799BA3C4BE2Q33349793-5CEB848D-1305-43E8-83A1-71410B213B6BQ33367007-9E9FF9CF-CEB5-44D5-988D-7932070739A2Q33620921-31F0970F-5F7B-4275-8D84-2ED9C9291309Q33783820-4AE9874B-56B0-406A-A022-AD836550DF06Q33801103-CFD3F475-68FD-4468-A6AE-D7461F570EDFQ34069791-2B6F6F72-C2C8-48F4-AFA4-57EBB8FCBD81Q34133986-AA9FE6F2-640C-40D2-8BD6-F58035837F8BQ34593906-F7A9D256-D2C8-4CCC-B77B-5272E275068DQ35853921-2A463FD4-A6F9-48E2-B724-3878A8BCAFD9Q35883539-A384E5C7-300D-49C3-BFF5-494C100CDE63Q35887752-1B4831FE-857C-471E-947F-856B3C3A94FBQ35928180-ED1EFD89-91E5-4D74-A715-98B035511B1DQ35929492-A93F946D-046A-4449-9D38-59235A9B91EEQ35929509-6B1EF961-6C02-4928-B6C1-C173EDF56A03Q35929560-DEE1ADAC-EE57-4EEF-92E8-79247E19FA8CQ35948180-FB6C769F-47E0-4E18-99BD-68C573B7F5C9Q36099083-65B9A72B-4062-43C8-9BB3-09E7441644BDQ36456552-EC44FE7C-A216-4437-8110-CF1F67047FF5Q36746968-7038572F-FFD6-4D07-8D9A-C0920E220821Q36953913-AB89602D-9C0B-4E29-9AE7-ACEADB799601Q37349055-7F885DCA-AA5A-4673-A7EB-2F01F0B12A61Q38210170-DA790BEB-1E38-43E2-9821-FACBDC5EFFFCQ38466790-62329A0D-17FF-45AF-80B4-7A545935561DQ39685314-B5094FDC-65B6-4F2D-A17F-95B9C245DE08Q39848883-495E5FA5-6707-4479-9310-B2B94AEB8E06Q40267080-202D9812-D99A-4DD5-8248-125B06024368Q40526618-4664583F-77D7-4DC0-A3EE-5A0D2EB7A059Q41725988-2EB4FC31-EFD1-4CB6-B4C6-1C029C10BBE9Q42285558-F1721387-0C27-49C4-AD81-D5A578A413E1Q43242573-68A96168-FAB7-4BDD-8AB6-404D0941EF7DQ44561674-4A26C829-910D-4D82-86DB-70D1ABD2A83BQ45355451-D1AA1440-41A9-4563-9E9A-C1C6D27B3BCBQ54300812-A52AEF33-9B90-401B-8D15-64B1B4ED6A65
P2860
The immunopathogenesis of equine infectious anemia virus.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The immunopathogenesis of equine infectious anemia virus.
@en
type
label
The immunopathogenesis of equine infectious anemia virus.
@en
prefLabel
The immunopathogenesis of equine infectious anemia virus.
@en
P2093
P1433
P1476
The immunopathogenesis of equine infectious anemia virus.
@en
P2093
P304
P356
10.1016/0168-1702(94)90038-8
P577
1994-05-01T00:00:00Z